Teladoc Health, Inc. (NYSE:TDOC) in recent session today was buoying at a fall of -1.81% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $237.07 and 5Y monthly beta was reading 0.44 with its price kept floating in the range of $230.13 and $240.00 on the day. Considering stock’s 52-week price range provides that TDOC hit a high price of $240 and saw its price falling to a low level of $54.58 during that period. Over a period of past 1-month, stock came adding 24.22% in its value.

With its current market valuation of $19.34 Billion, Teladoc Health, Inc. is set to declare its quarterly results on Oct 28, 2020- Nov 02, 2020. TDOC Stock’s Forward Dividend and its yield are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter. Analysts are in estimates of -$0.3 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$1.31 for 2020 with estimates of that growing to -$0.71 in next year. These estimates are suggesting current year growth of -0.05% for EPS and -0.46% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $270.28 Million. They suggested that in the process company could generate revenue of as low as $203.7 Million which could climb up to $285.77 Million to hit a high. The average estimate is representing an increase of 95.9% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $966.83 Million in 2020, which will be +74.7% more from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with 4 upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review TDOC stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 100% Buy for it.

According to ratings assigned by 27 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 13 of them are recommending Teladoc Health, Inc. (TDOC) as a Hold, while 13 are in view that stock is a Buy. Recommendation by None analysts for the stock is an Outperform while number of those analysts who rated the stock as Underperform is 1, whereas none of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.

Digging deeper we become aware of the PEG ratio of the TDOC stock which is currently positioned at 0. It further provides that stock’s current price level is 5.73% away from its 20-day simple moving average and is 18.63% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 64.06 while volatility remained at 5.97% over the past week which changes to 5.45% when measuring it over the past month. Beta is valued at 0.48, while measure of average true range or ATR is currently at 11.64. In predicting price targets of as low as $150 and as high as $275, analysts are in agreement on assigning the stock over the next 12 months average price target of $223.83. Stock’s current price level is -35.56% above from estimated low price target while it is 18.14% below the estimated high; and even if the TDOC’s share succeeded to reach the median price of $230, then the outlook of -1.19% could come to the excitement of the investors.

Having a second look at Teladoc Health, Inc. (NYSE:TDOC) provides that stock’s average daily trading volume for 3 months was 2.71 Million, while it dropped to 1.68 Million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock currently stood at 82.61 Million.

Data compiled by Thomson Reuters highlights that percentage of outstanding shares held by the insiders is 1.13% while it is 119.69% for the institutional holders. The figures also indicate that as of July 14, 2020, number of stock’s short shares was 7550000 which implies a short ratio of 2.67. This shows up a 9.13% of Short Interest in company’s outstanding shares on the day. In July the standing of shares short declined as it was 8.05 Million in the previous month. Addition of +183.17% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.